{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:04:47Z","timestamp":1784189087960,"version":"3.55.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s40273-026-01626-z","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T14:11:51Z","timestamp":1779459111000},"page":"899-906","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Using Proportional and Absolute Shortfall in Reimbursement Decision-Making in the Netherlands: Implications for Oncology Drugs for Older Patients"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8722-3431","authenticated-orcid":false,"given":"Vivian","family":"Reckers-Droog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steef","family":"Redeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Busschbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Vijgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e8l","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonneke","family":"Timmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"1626_CR1","first-page":"1","volume-title":"Cost-effectiveness in practice","author":"Zorginstituut Nederland","year":"2015","unstructured":"Zorginstituut Nederland. Cost-effectiveness in practice. Diemen: Zorginstituut Nederland; 2015. p. 1\u201340."},{"key":"1626_CR2","volume-title":"Zinnige en duurzame zorg","author":"Raad voor de Volksgezondheid en Zorg","year":"2006","unstructured":"Raad voor de Volksgezondheid en Zorg. Zinnige en duurzame zorg. Den Haag: RVZ; 2006."},{"key":"1626_CR3","first-page":"1","volume-title":"Ziektelast in de praktijk","author":"Zorginstituut Nederland","year":"2018","unstructured":"Zorginstituut Nederland. Ziektelast in de praktijk. Diemen: Zorginstituut Nederland; 2018. p. 1\u201334."},{"issue":"6","key":"1626_CR4","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.healthpol.2018.04.001","volume":"122","author":"VT Reckers-Droog","year":"2018","unstructured":"Reckers-Droog VT, van Exel NJA, Brouwer WBF. Looking back and moving forward: on the application of proportional shortfall in healthcare priority setting in the Netherlands. Health Policy. 2018;122(6):621\u20139.","journal-title":"Health Policy"},{"key":"1626_CR5","unstructured":"Magnussen JAM, Granaas T, Magelssen M. Severity of illness and priority setting in Norway. Summary of a report from a working group. 2015."},{"key":"1626_CR6","unstructured":"Lasys T. Lithuanian experience: determining a willingness-to pay threshold. 2022."},{"key":"1626_CR7","unstructured":"Anspal S, J\u00e4rve J, S\u00f5mer M. Assessment process and decision criteria of health technologies in Estonia\u2014final report. 2022."},{"key":"1626_CR8","unstructured":"Wailoo A. Severity weights in NICE technology appraisals. A NICE DSU report. 2024."},{"key":"1626_CR9","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200422170-00001","author":"EA Stolk","year":"2004","unstructured":"Stolk EA, Van Donselaar G, Brouwer WBF, et al. Reconciliation of economic concerns and health policy. Illustration of an equity adjustment procedure using proportional shortfall. Pharmacoeconomics. 2004. https:\/\/doi.org\/10.2165\/00019053-200422170-00001.","journal-title":"Pharmacoeconomics"},{"key":"1626_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.socscimed.2004.05.003","volume":"60","author":"E Nord","year":"2005","unstructured":"Nord E. Concerns for the worse off: Fair innings versus severity. Soc Sci Med. 2005;60:257\u201363.","journal-title":"Soc Sci Med"},{"key":"1626_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-3-319-21112-1_13","volume-title":"Prioritization in medicine: an international dialogue","author":"G Bognar","year":"2016","unstructured":"Bognar G. Priority setting and age. In: Nagel E, Lauerer M, editors. Prioritization in medicine: an international dialogue. Cham: Springer; 2016. p. 163\u201377."},{"key":"1626_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.07.012","author":"V Reckers-Droog","year":"2019","unstructured":"Reckers-Droog V, van Exel J, Brouwer W. Equity weights for priority setting in healthcare: severity, age, or both? Value Health. 2019. https:\/\/doi.org\/10.1016\/j.jval.2019.07.012.","journal-title":"Value Health"},{"key":"1626_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.01.012","author":"V Reckers-Droog","year":"2021","unstructured":"Reckers-Droog V, van Exel J, Brouwer W. Willingness to pay for health-related quality of life gains in relation to disease severity and the age of patients. Value Health. 2021. https:\/\/doi.org\/10.1016\/j.jval.2021.01.012.","journal-title":"Value Health"},{"key":"1626_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-B","author":"A Williams","year":"1997","unstructured":"Williams A. Intergenerational equity: an exploration of the \u201cfair innings\u201d argument. Health Econ. 1997. https:\/\/doi.org\/10.1002\/(SICI)1099-1050(199703)6:2%3c117::AID-HEC256%3e3.0.CO;2-B.","journal-title":"Health Econ"}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-026-01626-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40273-026-01626-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-026-01626-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:20:50Z","timestamp":1784186450000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40273-026-01626-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1626"],"URL":"https:\/\/doi.org\/10.1007\/s40273-026-01626-z","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"value":"1170-7690","type":"print"},{"value":"1179-2027","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Reckers-Droog reports no conflict of interest. Dr. Redeker reports being employed by the National Health Care Institute (Zorginstituut Nederland,\u00a0ZIN). Dr. Busschbach reports being member of the Insured Package Advisory Committee (Adviescommissie Pakket,\u00a0ACP). Dr. Vijgen reports being employed by the National Health Care Institute (Zorginstituut Nederland,\u00a0ZIN). Ms. Link reports being employed by the National Health Care Institute (Zorginstituut Nederland,\u00a0ZIN). Dr. Timmers reports being employed by the National Health Care Institute (Zorginstituut Nederland,\u00a0ZIN). No other conflicts of interest are reported.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this study according to the Medical Research Involving Human Subjects Act in the Netherlands.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ChatGPT (GPT-5) by OpenAI was used in a limited capacity to support this work, specifically for language refinement and grammar checking. All content, analyses, interpretations, and conclusions were conceived, written, and verified by the authors.","order":3,"name":"Ethics","label":"AI Use and Disclosure Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Conceptualization: Vivian Reckers-Droog, Steef Redeker, Jan Busschbach, Sylvia Vijgen, Ang\u00e8l Link, Lonneke Timmers; methodology: Vivian Reckers-Droog, Steef Redeker; Software: Vivian Reckers-Droog, Steef Redeker; validation: Vivian Reckers-Droog, Steef Redeker; Formal analysis: Vivian Reckers-Droog, Steef Redeker; investigation: Vivian Reckers-Droog, Steef Redeker; Resources: Steef Redeker, Ang\u00e8l Link; writing \u2013 original draft preparation: Vivian Reckers-Droog; writing \u2013 review and editing: Vivian Reckers-Droog, Steef Redeker, Jan Busschbach, Sylvia Vijgen, Ang\u00e8l Link, Lonneke Timmers; Visualization: Vivian Reckers-Droog; Steef Redeker; supervision: Jan Busschbach, Lonneke Timmers; project administration: Vivian Reckers-Droog; Steef Redeker.","order":4,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}